Literature DB >> 2081921

Effects of sex steroid hormones on pancreatic cancer in the rat.

D S Longnecker1, C Sumi.   

Abstract

The incidence of spontaneous and induced neoplasms of the exocrine pancreas in rats is higher in males than in females. Castration, ovariectomy, and hormone replacement with estradiol and testosterone have been shown to influence the growth of carcinogen-induced preneoplastic foci in the azaserine-rat model of pancreatic carcinogenesis. Similar hormonal treatments have also influenced the growth of an azaserine-induced poorly differentiated acinar cell carcinoma that can be transplanted syngeneically in Lewis rats. The effect on growth of preneoplastic lesions and carcinomas is similar. The preneoplastic lesions and transplanted tumors grow faster in intact male rats than in castrated rats, and the growth of the lesions and tumors is inhibited by estrogen treatment. It appears that testosterone supports the growth of preneoplastic foci and carcinomas, whereas estrogen inhibits such growth. The mechanism is unknown and may be direct, or an indirect effect may be mediated through a peptide hormone. Tamoxifen treatment did not significantly influence the growth of the transplanted carcinomas in the rat model.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2081921     DOI: 10.1007/BF02924233

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  14 in total

1.  Cancer statistics, 1989.

Authors:  E Silverberg; J A Lubera
Journal:  CA Cancer J Clin       Date:  1989 Jan-Feb       Impact factor: 508.702

2.  Carcinoma of the exocrine pancreas: a sex hormone responsive tumour?

Authors:  B A Greenway
Journal:  Br J Surg       Date:  1987-06       Impact factor: 6.939

3.  Antiestrogen therapy in pancreatic carcinoma: a preliminary report.

Authors:  K Tønnesen; M Kamp-Jensen
Journal:  Eur J Surg Oncol       Date:  1986-03       Impact factor: 4.424

4.  Tamoxifen therapy in unresectable adenocarcinoma of the pancreas.

Authors:  A Wong; A Chan; K Arthur
Journal:  Cancer Treat Rep       Date:  1987 Jul-Aug

5.  Inhibitory effects of estrogen and castration on the early stage of pancreatic carcinogenesis in Fischer rats treated with azaserine.

Authors:  C Sumi; D S Longnecker; B D Roebuck; T Brinck-Johnsen
Journal:  Cancer Res       Date:  1989-05-01       Impact factor: 12.701

6.  Adenocarcinoma of the pancreas--a hormone sensitive tumor? A preliminary report on Nolvadex treatment.

Authors:  N O Theve; A Pousette; K Carlström
Journal:  Clin Oncol       Date:  1983-09

7.  Divergent effects of retinoids on pancreatic and liver carcinogenesis in azaserine-treated rats.

Authors:  D S Longnecker; E T Kuhlmann; T J Curphey
Journal:  Cancer Res       Date:  1983-07       Impact factor: 12.701

8.  Effect of castration and hormone replacement on azaserine-induced pancreatic carcinogenesis in male and female Fischer rats.

Authors:  E F Lhoste; B D Roebuck; T Brinck-Johnsen; D S Longnecker
Journal:  Carcinogenesis       Date:  1987-05       Impact factor: 4.944

9.  Effect of orchiectomy and testosterone on the early stages of azaserine-induced pancreatic carcinogenesis in the rat.

Authors:  E F Lhoste; B D Roebuck; J E Stern; D S Longnecker
Journal:  Pancreas       Date:  1987       Impact factor: 3.327

Review 10.  Androgen influence on exocrine pancreatic cancer.

Authors:  A Andrén-Sandberg
Journal:  Int J Pancreatol       Date:  1989-05
View more
  12 in total

Review 1.  Chemoprevention for pancreatic cancer.

Authors:  Robert A Wolff
Journal:  Int J Gastrointest Cancer       Date:  2003

2.  Human pancreas-specific protein disulfide isomerase homolog (PDIp) is an intracellular estrogen-binding protein that modulates estrogen levels and actions in target cells.

Authors:  Xin-Miao Fu; Bao Ting Zhu
Journal:  J Steroid Biochem Mol Biol       Date:  2009-02-21       Impact factor: 4.292

3.  Establishment of a transplantable carcinoma arising from the intrahepatic bile duct in Syrian golden hamsters.

Authors:  T Fukahori; T Tomioka; K Inoue; Y Tajima; T Tsunoda; T Kanematsu
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 4.  Hormonal therapy of pancreatic carcinoma. Rationale and perspectives.

Authors:  D Perilli; C Mansi; V Savarino; G Celle
Journal:  Int J Pancreatol       Date:  1993-06

5.  Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California.

Authors:  Eric J Duell; Elizabeth A Holly; Karl T Kelsey; Paige M Bracci
Journal:  Int J Cancer       Date:  2010-02-01       Impact factor: 7.396

6.  Gender differences in chemical carcinogenesis in National Toxicology Program 2-year bioassays.

Authors:  Sandeep Kadekar; Shyamal Peddada; Ilona Silins; John E French; Johan Högberg; Ulla Stenius
Journal:  Toxicol Pathol       Date:  2012-05-14       Impact factor: 1.902

7.  Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study.

Authors:  Omid Sadr-Azodi; Peter Konings; Nele Brusselaers
Journal:  United European Gastroenterol J       Date:  2017-04-09       Impact factor: 4.623

8.  Exocrine pancreatic carcinogenesis and autotaxin expression.

Authors:  Sandeep Kadekar; Ilona Silins; Anna Korhonen; Kristian Dreij; Lauy Al-Anati; Johan Högberg; Ulla Stenius
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

9.  Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies.

Authors:  Hong-Bo Guan; Lang Wu; Qi-Jun Wu; Jingjing Zhu; Tingting Gong
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

10.  Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.

Authors:  P Watanapa; B Flaks; H Oztas; P H Deprez; J Calam; R C Williamson
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.